Click any tag below to further narrow down your results
Links
OpenAI is rolling out ChatGPT Health to all U.S. users over 18 on free and paid plans, letting them link personal data from Apple Health, Epic and other platforms. The feature, tested since January amid rising health queries and a lawsuit over bad advice, still carries a disclaimer against using it for formal diagnosis.
- ChatGPT Health is now available to all US users 18+ across free and paid plans, letting them connect data from Apple Health, Epic, and similar platforms into any chat.
- Health-related queries on ChatGPT have jumped from 230 million to 300 million per week since January testing began.
- OpenAI still disclaims the tool for diagnosis or treatment, a stance relevant to a lawsuit claiming ChatGPT discouraged a Florida pastor from seeing a doctor.
This TLDR roundup covers AWS’s plan to start selling its Trainium AI chips to outsiders, and Midjourney’s launch of a full-body ultrasound scanner for its new health spas. It also highlights NASA’s award to Relativity Space for a Mars orbiter, the shift to usage-based AI pricing, the deep dive on agent loop architecture, plus Intel’s stock jump and warnings about the “infinite workweek.”
- AWS is in talks to sell Trainium AI chips to outside data centers, directly challenging Nvidia despite its own capacity already being maxed out.
- Midjourney is launching a (non-AI) full-body ultrasound scanner called the "Midjourney Scanner," planning 50,000 units starting with a branded SF spa.
- AI companies are shifting from flat-fee subscriptions to usage-based pricing, pushing customers to monitor and justify each query's cost.
- Intel's stock jumped after Trump and Apple announced a US chipmaking partnership under CEO Lip-Bu Tan.
This article profiles eight healthcare services companies using AI across their care stacks to cut costs, speed up treatment, and boost patient engagement. From smarter caregiver scheduling at Honor to AI-driven patient outreach at Cityblock, each example shows measurable improvements in outcomes, efficiency, or retention. The piece argues that service-focused models with embedded AI have a durable edge over pure software plays.
- Honor cut home-caregiver churn from an industry-standard 85% annually down to the mid-30s by using AI to match schedules to caregivers' actual behavior, not just stated preferences.
- Ro's AI triage tool slashed median patient response time from under 2 hours to 33 minutes, answering urgent messages in 26 minutes or less.
- Aledade's EHR Overlay is live in 85%+ of eligible practices and made diabetic patients 40% more likely to fill statin prescriptions within two weeks.
- The article's core argument: embedding AI into service delivery (not just selling standalone software) is what's driving durable, measurable gains in cost, speed, and engagement across these companies.
OpenAI has introduced a Health mode for ChatGPT, allowing users to securely share health information and connect medical records and wearables. While this aims to enhance accessibility and privacy, concerns arise over the potential for misleading medical advice and data security, especially given previous incidents involving harmful guidance.
- OpenAI launched a Health mode letting ChatGPT users connect medical records and wearables, claiming encrypted, separate storage from regular chat history despite not being HIPAA-compliant.
- Over 230 million people already ask ChatGPT medical questions weekly, so this formalizes existing behavior rather than creating new use.
- Past cases of harmful chatbot advice leading to hospitalization or death raise doubts about safety despite physician-shaped guidelines meant to redirect users to real doctors.
- Mental health support was notably excluded from the update, raising questions about OpenAI's priorities on user safety.
Withings introduces the Body Scan 2, a $600 smart scale designed to provide comprehensive health insights by measuring over 60 biomarkers related to longevity and chronic illness risk. The device, equipped with medical-grade technologies, aims to help users spot early signs of health issues and make lifestyle adjustments for better long-term health outcomes.
- The Body Scan 2 costs $600 and measures over 60 biomarkers tied to longevity and chronic illness risk, including hypertension and early glycemic dysregulation
- It uses 8 embedded electrodes plus 4 in a handle/pull-up bar to generate a "Health Trajectory" score via the Withings app
- Launching Q2 2026, it's still pending FDA clearance for certain metrics
- Withings claims GDPR/HIPAA-compliant data privacy as part of the pitch